Market Structure and Competition: Assessment of Malaysian Pharmaceutical Industry based on the Modified Structure-Conduct-Performance Paradigm

Chong, Hooi Ying and Chan, Tze-Haw (2014): Market Structure and Competition: Assessment of Malaysian Pharmaceutical Industry based on the Modified Structure-Conduct-Performance Paradigm. Forthcoming in: The International Journal Of Organizational Innovation , Vol. 7, No. 3 (1 November 2014): pp. 137-150.

Abstract

This study assesses the market structure and competitiveness of Malaysian pharmaceutical industry. A panel analysis of 41 pharmaceutical manufacturing firms over 2004-2012 is conducted founded on the modified Structure-Conduct-Performance (SCP) framework. Our study reveals that the Malaysian pharmaceutical industry is highly concentrated (oligopoly) and the major findings are threefold. First, anti-competitive practices subsist among the pharmaceutical firms. Major players may have greater control over the markets and potentially colluded to gain better profits. Second, selling intensity is evident to raise the firms’ business performance, suggesting that advertisement, marketing campaigns, product differentiations and distribution efforts could be effective in building competencies over the rivals. Third, the study has tackled the endogeneity problem of traditional SCP with dual causal effects found between business conduct and business performance. Firms and authorities should consider the interactive mutual influences of structure-conduct-performance when formulating their respective management decisions and regulatory rules.

• Item Type: MPRA Paper
• Language: English
• Keywords: Modified Structure-Conduct-Performance, Pharmaceutical Industry, Competition, Panel Regression, Panel Causality
• Subjects: D - Microeconomics > D2 - Production and Organizations; I - Health, Education, and Welfare > I1 - Health > I15 - Health and Economic Development; L - Industrial Organization > L1 - Market Structure, Firm Strategy, and Market Performance

References

Athanasoglou, P. P., Brissimis, S. N. and Delis, M.D. (2006). Bank-specific, industry-specific and macroeconomic determinants of bank profitability. Journal of International Financial Markets, Institutions & Money, 18(2008), 121-136.

Babar, Z., Ibrahim MIM, Singh H, Bukahri N.I. and Creese A (2007). Evaluating drug prices, availability, affordability, and price components: Implications for access to drugs in Malaysia. PLoS Med4(3):e82.doi:10.1371/journal.pmed.0040082

Behname, M. (2012). The compare of concentration and efficiency in banking industry: Evidence from the OPEC countries. Eurasian Journal of Business and Economics, 5(10), 15-24.

Ding, M.C, Wang, D. & Wang, Y. (2011). SCP paradigm analysis and countermeasures of China’s automobile industry. Journal of Sustainable Development, 4(2), 211-216.

Ferreira, C. (2014). Panel Granger causality between bank efficiency and market concentration in the European Union. Research in Applied Economics, 6(1).

Gujarati, D. N. and Sangeetha. (2007). Basic econometrics. 4th Edition. Tata Mcgraw-Hill: New Delhi.

Lee C-C (2012). The causal correlations among market structure, conduct and performance of the CPA industry. The Service Industries Journal, 32(3), 431-450.

Maniatis, P. (2006). Market concentration and industry profitability: the case of Greek banking (1997-2004). International Business & Economics Research Journal, 5(10).

Mensi, S. and Zouari, A. (2011). Banking industry, market structure and efficiency: The revisited model to intermediary hypotheses. International Journal of Economic Research, 2(1). 23-36.

Mishra, P. and Chandra, T. (2010). Mergers, acquisitions and firms’ performance: Experience of Indian pharmaceutical industry. Eurasian Journal of Business and Economics, 3(5), 111-126.

Mishra, P. and Vikas (2010). Structure, conduct and performance in Indian pharmaceutical industry: A simultaneous equations investigation. Review of Development and Change, 15(1), 69-99.

National Pharmaceutical Control Bureau (2013). Industry: List of manufacturers. Retrieved from: http://portal.bpfk.gov.my/product_search.cfm?type=2

New Straits Time (2011). Competition countdown: Level playing field. Retrievedfrom:http://www.nst.com.my/opinion/columnist/competition-countdown-level-playing-field-1.4678

Park, K.H. (2012). Bank mergers and competition in Japan. International Journal of Banking and Finance, 9(2), 1-25.

Sarita, B., Zandi, G., and Shahabi, A. (2012). Determination of performance in Indonesian Banking: A cross-sectional and dynamic panel data analysis. International Journal of Economics and Finance Studies, 4(2).

Sahoo, D. and Mishra, P. (2012). Structure, conduct and performance of Indian Banking Sector. Review of Economic Perspectives, 12(4), 235-264.

Shaik, S., Allen, A.J., Edwards. S. and Harris, J. (2009). Market structure conduct and performance hypothesis revisited using stochastic frontier efficiency analysis. Journal of Transportation Research Forum, 48(3), 5-18.

Tung G-S, Lin C-Y and Wang C-Y (2010). The market structure, conduct and performance paradigm re-applied to the international tourist hotel industry. African Journal of Business Management, 4(6), 1116-1125.

Umar Mu’azu, A.R., Mohamed, Z., Shamsudin, M.N. and Latif, I.A. (2013). Structure-conduct-performance of the Malaysian poultry industry. Australian Journal of Basic and Applied Science, 7(8), 170-177.

Vyas, V., Narayanan, K., and Ramanathan, A. (2012). Determinants of mergers and acquisitions in Indian pharmaceutical industry. Eurasian Journal of Business and Economics, 5(9), 79-102.

Zhang Y-C and Li S-L. (2009). High performance work practices and firm performance: Evidence from the pharmaceutical industry in China. The International Journal of Human Resource Management, 20(11), 2331-2348.